Holly L. PeayNuchanart Q. OrmsbyGail E. HendersonThidarat JupimaiStuart RennieKrittaecho SiripassornKunakorn KanchaweeSinéad IsaacsonR. Jean CadiganKriste KuczynskiUdom LikhitwonnawutRTI InternationalChulalongkorn UniversityThe University of North Carolina at Chapel HillMahidol UniversityThailand National CAB on HIV researchBamrasnaradura Infectious Diseases Institute2020-12-282020-12-282020-11-01International Health. Vol.12, No.6 (2020), 567-57418763405187634132-s2.0-85095979231https://repository.li.mahidol.ac.th/handle/123456789/60576© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Background: The social/behavioral HIV Decision-Making Study (DMS) assesses informed consent and trial experiences of individuals in HIV remission trials in Thailand. We convened a 1-d multi-stakeholder participatory workshop in Bangkok. We provide a meeting summary and reactions from DMS investigators. Methods: Workshop members viewed de-identified interview excerpts from DMS participants. They deliberated on the findings and made recommendations regarding informed choice for remission trials. Notes and recordings were used to create a summary report, which was reviewed by members and refined. Results: Workshop members’ recommendations included HIV education and psychosocial support to establish the basis for informed choice, key trial information to be provided in everyday language, supportive decision-making processes and psychosocial care during and after the trial. Concerns included participant willingness to restart antiretrovirals after trial-mandated treatment interruption, unintended influence of the research team on decision-making and seemingly altruistic motivations for trial participation that may signal attempts to atone for stigmatized behavior. Conclusions: The workshop highlighted community perspectives and resulted in recommendations for supporting informed choice and psychosocial and physical health. These are the first such recommendations arising from a deliberative process. Although some elements are rooted in the Thai context, most are applicable across remission trials.Mahidol UniversityMedicineRecommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: Report from a participatory workshopArticleSCOPUS10.1093/inthealth/ihaa067